![](/img/cover-not-exists.png)
Abstract No. 526 CheckMate-9DX: phase 3, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
Exposito, M. Jimenez, Akce, M., Alvarez, J., Assenat, E., Balart, L., Baron, A., Decaens, T., Heurgue-Berlot, A., Martin, A., Paik, S., Poulart, V., Sehbai, A., Shimada, M., Takemura, N., Yoon, J.Volume:
30
Language:
english
Journal:
Journal of Vascular and Interventional Radiology
DOI:
10.1016/j.jvir.2018.12.607
Date:
March, 2019
File:
PDF, 71 KB
english, 2019